Research by Guangzhou Institute of Respiratory Health has confirmed that Lianhua Qingwen has a significant inhibitory effect on Omicron variant strains

Recently, the results of the in vitro experiments of Lianhua Qingwen against the new coronavirus Omicron variant conducted by the Guangzhou Institute of Respiratory Health were released
.

The study found that Lianhua Qingwen has a significant inhibitory effect on the proliferation of the new coronavirus Omikron variant, and has a significant inhibitory effect on the cytopathic effect induced by the infection

Infect

Lianhua Qingwen Capsule is an innovative patented traditional Chinese medicine researched and developed by the team of Academician Wu Yiling of the State Key Laboratory of Collateral Disease Research and Innovative Traditional Chinese Medicine.
Won the second prize of National Science and Technology Progress Award in 2011
.

Since the outbreak of the new crown epidemic, the Guangzhou Institute of Respiratory Health Research on Lianhua Qingwen's anti-new crown virus and new crown variants has not stopped

COVID-19

Lianhua Qingwen has obtained definite clinical research evidence for the prevention and treatment of new coronary pneumonia
.

The results of the "Prospective, Randomized, Controlled, Multi-Center Clinical Study of Traditional Chinese Medicine Lianhua Qingwen Capsules in the Treatment of Novel Coronavirus Pneumonia" published in the European authoritative journal "Plant Medicine" showed that the oral administration of Lianhua Qingwen Capsules combined with conventional treatment 14 days can significantly improve the disappearance rate of new coronary pneumonia fever, fatigue, cough and other clinical symptoms, shorten the duration of symptoms, CT imaging shows that the lung inflammation is improved, the clinical cure rate is improved, and it shows a good trend in reducing the rate of exacerbation

Coronavirus disease

The results of the real-world study of "Lianhua Qingwen Capsules to Prevent Novel Coronavirus Pneumonia" published in the international academic journal "Evidence-Based Complementary and Alternative Medicine" showed that the nucleic acid test of Lianhua Qingwen treatment group was positive during the isolation medical observation period (14 days).
The nucleic acid detection rate was 0.
27% in the control group and 1.
14% in the control group; among the second close contacts, the positive rate of nucleic acid detection in the Lianhua Qingwen treatment group was 0.
09% and that in the control group was 0.
71%
.

The treatment group taking Lianhua Qingwen was significantly lower than the control group

prevention

The in vitro experiments of Lianhua Qingwen on the mutants of Omicron have shown good results.

       Lianhua Qingwen Capsule has played an important role in the prevention and control of the epidemic at home and abroad, especially under the new situation that the Omicron variant is hitting our country, it is of great practical significance to make good use of Chinese patent medicine to carry out mass prevention and treatment

 

 

leave a message here